GenEra Overview
- Founded
- 1998

- Status
- Acquired/Merged
- Employees
- 12

- Latest Deal Type
- M&A
- Financing Rounds
- 1
GenEra General Information
Description
Operator of a biotechnology company specializing in the fields of gene transfer and gene therapy. The company develops a variety of genetically modified tissues as a means of treating a range of diseases that are caused by defects in circulating proteins and other molecules, such as high cholesterol levels.
Contact Information
- Istituto Scientifico H. San Raffaele
- Via Olgettina, 58
- 20132 Milan
- Italy
GenEra Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore GenEra‘s full profile, request access.
Request a free trialGenEra Patents
GenEra Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2415999-A | A method for the positive selection of cd4+ t-lymphocytes transduced with anti-hiv genes | Abandoned | 23-Dec-1997 | 000000000 | |
EP-1030908-A1 | Genetically-modified myogenic progenitors and their use in cell and gene therapy | Withdrawn | 14-Nov-1997 | 0000000000 | |
CA-2310016-A1 | Genetically-modified myogenic progenitors and their use in cell and gene therapy | Abandoned | 14-Nov-1997 | 0000000000 | |
AU-1872599-A | Genetically-modified myogenic progenitors and their use in cell and gene therapy | Abandoned | 14-Nov-1997 | 0000000000 | |
JP-2001523448-A | Genetically modified myogenic precursors and their use in cells and gene therapy | Pending | 14-Nov-1997 | C12N5/0663 |
GenEra Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial